Federated Hermes’s Coherus Oncology, Inc. Common Stock CHRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-582
Closed -$605 2091
2024
Q3
$605 Buy
+582
New +$605 ﹤0.01% 1990
2022
Q4
Sell
-4,223
Closed -$41K 2177
2022
Q3
$41K Buy
4,223
+1,498
+55% +$14.5K ﹤0.01% 1696
2022
Q2
$20K Sell
2,725
-2,214
-45% -$16.3K ﹤0.01% 1763
2022
Q1
$64K Buy
4,939
+708
+17% +$9.17K ﹤0.01% 1709
2021
Q4
$68K Sell
4,231
-6,900
-62% -$111K ﹤0.01% 1753
2021
Q3
$179K Buy
+11,131
New +$179K ﹤0.01% 1680
2021
Q2
Sell
-161
Closed -$2K 2219
2021
Q1
$2K Sell
161
-49,905
-100% -$620K ﹤0.01% 2115
2020
Q4
$870K Buy
50,066
+425
+0.9% +$7.39K ﹤0.01% 1371
2020
Q3
$910K Buy
+49,641
New +$910K ﹤0.01% 1267
2019
Q4
Sell
-329,979
Closed -$6.69M 2221
2019
Q3
$6.69M Sell
329,979
-227,259
-41% -$4.6M 0.02% 687
2019
Q2
$12.3M Buy
+557,238
New +$12.3M 0.03% 506
2019
Q1
Sell
-1,348
Closed -$12K 2154
2018
Q4
$12K Sell
1,348
-134,723
-99% -$1.2M ﹤0.01% 1845
2018
Q3
$2.25M Buy
136,071
+82,334
+153% +$1.36M 0.01% 1048
2018
Q2
$752K Buy
53,737
+52,226
+3,456% +$731K ﹤0.01% 1365
2018
Q1
$17K Buy
1,511
+80
+6% +$900 ﹤0.01% 1784
2017
Q4
$13K Sell
1,431
-38
-3% -$345 ﹤0.01% 1831
2017
Q3
$20K Buy
+1,469
New +$20K ﹤0.01% 1750
2016
Q1
Sell
-284,000
Closed -$6.52M 2108
2015
Q4
$6.52M Sell
284,000
-126,200
-31% -$2.9M 0.02% 514
2015
Q3
$8.22M Hold
410,200
0.03% 466
2015
Q2
$11.9M Buy
+410,200
New +$11.9M 0.04% 433